Olfactory Biosciences Corp. Offers Reseller/Affiliate Program for Autism Aid Balm
18 10월 2013 - 8:38PM
Marketwired
Olfactory Biosciences Corp. Offers Reseller/Affiliate Program for
Autism Aid Balm
PHILADELPHIA, PA--(Marketwired - Oct 18, 2013) - Olfactory
Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Aid
Balm™, is pleased to announce today that they are accepting
requests for reseller opportunities. There are limited
opportunities available. This decision has come as a result of
increasing sales volumes and the desire OLFC has for people to have
a more personalized attention from a local reseller.
This is an entry level program for resellers/affiliates looking
to offer Autism Spectrum products. Anyone awarded a reseller
agreement will receive credit towards product for resale from any
prior purchases they have made of the NOXO Autism Aid Balm™. As
they demonstrate the ability to sell product, resellers will
qualify to be able to resell additional OLFC products. Advertising
materials and reseller support will be provided by OLFC in order to
guarantee quality, accurate information and support for their
clients.
NOXO's solution provides unprecedented hope for families
isolated by behavioral issues related to sensitivities and
overstimulation in children with Autism. NOXO Autism Balm is
similar to a lip balm but is applied just below the nostrils on the
upper lip. Allowing the natural formula to be inhaled and take
effect. NOXO's solution is safe, easy to apply and non-invasive. It
works on your body's natural processes and responses.
NOXO Autism Aid Balm™ retails for $29.95 and all resellers will
receive wholesale pricing as defined in their agreement. We are
excited to work with you. Contact us today at 484-278-1626 or visit
our Web Site pages below.
www.noxoinfo.com/autism
www.noxoinfo.com/contact
About Olfactory Biosciences Corp www.noxoinfo.com/investor
Olfactory Biosciences Corp.'s NOXO division is focused to
develop a variety of products targeting Olfactory Receptors for the
desired effect. These alternative medicine wellness products may
modify behavior or provide relief to common behavior challenges
such as anxiety, smoking or weight control, as examples.
FORWARD-LOOKING STATEMENTS
"Safe Harbor" Statement under the Private Securities Litigation
Reform Act of 1995: Statements by the Company, statements regarding
the NOXO product line, optimism related to the business, expanding
ales and other statements in this press release are forward-looking
statements within the meaning of the Securities Litigation Reform
Act of 1995. Such statements are based on current expectations,
estimates and projections about the Company's business. Words such
as expects, anticipates, intends, plans, believes, sees, estimates
and variations of such words and similar expressions are intended
to identify such forward-looking statements. These statements are
not guarantees of future performance and involve certain risks and
uncertainties that are difficult to predict. Actual results could
vary materially from the description contained herein due to many
factors including continued market acceptance of the Company's
products or the need to raise additional capital. In addition,
actual results could vary materially based on changes or slower
growth in the indoor garden market; the potential inability to
realize expected benefits and synergies; domestic and international
business and economic conditions; changes in customer demand or
ordering patterns; changes in the competitive environment including
pricing pressures or technological changes; technological advances;
shortages of manufacturing capacity; future production variables
impacting excess inventory and other risk factors listed from time
to time in the Company's Securities and Exchange Commission (SEC)
filings under "risk factors" and elsewhere. The forward-looking
statements contained in this press release speak only as of the
date on which they are made, and the Company does not undertake any
obligation to update any forward-looking statement to reflect
events or circumstances after the date of this press release.
Richard Stevenson President Olfactory Biosciences Corp. 333 E.
Lancaster Ave. Suite 317 Wynnewood, PA 19096, USA Phone:
484-278-1626
(USOTC:OLFC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
(USOTC:OLFC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024